Monthly Prescribing Reference

Vimpat Approved for Primary Generalized Tonic-Clonic Seizures

The FDA also approved Vimpat Injection for use in pediatric patients 4 years of age and older. The Food and Drug Administration (FDA) has approved Vimpat ® (lacosamide; UCB) as adjunctive therapy in ...
Drug Store News

FDA approves expanded indications for UCB’s Vimpat

More patients with epilepsy have a treatment option following the Food and Drug Administration's approval of an indication expansion for UCB's Vimpat (lacosamide) CV. The agency approved Vimpat as ...
Healio

VIDEO: Primary generalized tonic-clonic seizures pressing health issue for adolescents

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio DENVER — Primary generalized tonic-clonic ...
Nasdaq

Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures

TOKYO, May 13, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has received approval in China for the additional indication of its in-house discovered antiepileptic drug (AED) ...
Monthly Prescribing Reference

Eprontia Oral Solution Approved for Partial-Onset, Primary Generalized Tonic-Clonic Seizures

Credit: Shutterstock. Eprontia is approved for the treatment of partial-onset or primary generalized tonic-clonic seizures and migraine prevention. The Food and Drug Administration (FDA) has approved ...
Nasdaq

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug ...

LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with ...